期刊文献+

卡巴拉汀中间体3-[(1-二甲氨基)乙基]苯酚的合成

Synthesis of intermediate of rivastigmine:3-(1-dimethylaminoethyl)phenol
原文传递
导出
摘要 以间羟基苯乙酮为原料,硼氢化钠还原,与甲胺在醇溶液中发生Borch还原胺化反应,制得3-[(1-甲氨基)乙基]苯酚;将40%的甲醛溶液滴入3-[(1-甲氨基)乙基]苯酚的甲醇溶液中,控温0~5℃,硼氢化钠还原,得到目标化合物3-[(1-二甲氨基)乙基]苯酚,其结构经^(1)H-NMR和LC/MS表征。产物纯度为99.3%,反应总收率63.1%(以间羟基苯乙酮计)。该制备工艺原料易得、反应步骤少、操作简便、收率较高,可用于工业化生产。 The target compound 3-(1-methylaminoethyl)phenol was synthesized through Borch reductive amination reaction between m-acetylphenol and methylamine with sodium borohydride as reducing agent in the alcohol solution.The intermediate of rivastigmine 3-(1-dimethylaminoethyl)phenol was prepared by using 40%formaldehyde solution and 3-(1-methylaminoethyl)phenol as the raw materials under 0~5℃with the reductant of sodium borohydride in the methanol solution.The structure of the final product was characterized by ^(1)H-NMR and LC/MS.The purity of the product was 99.3%,and the total yield was 63.1%(calculated based on macetylphenol).This preparation process was easy to obtain raw materials,less reaction steps,simple operation,high yield,and can be used in industrial production.
作者 李杰镇 乔卉莹 张达志 LI Jie-zhen;QIAO Hui-ying;ZHANG Da-zhi(School of Chemical Engineering,Xuzhou College of Industrial Technology,Xuzhou 221140,China)
出处 《精细与专用化学品》 CAS 2023年第5期1-4,21,共5页 Fine and Specialty Chemicals
基金 国家自然科学基金面上项目(22178097) 江苏省自然科学基金面上项目(BK20211228)。
关键词 间羟基苯乙酮 卡巴拉汀 3-[(1-二甲氨基)乙基]苯酚 还原胺化 m-acetylphenol rivastigmine 3-(1-dimethylaminoethyl)phenol reductive amination reaction
  • 相关文献

参考文献5

二级参考文献47

  • 1冯金,陈卫民,孙平华.重酒石酸卡巴拉汀的合成[J].南方医科大学学报,2007,27(2):177-180. 被引量:5
  • 2周黎丽,周鸣强,吴贝,邓勇.重酒石酸利斯的明的合成[J].中国医药工业杂志,2007,38(5):327-329. 被引量:4
  • 3Davenport KG,Sheldon PA,Le Bars J,et al.Process for perparing4-hydroxyacetophenone oxime[P].US:5466869,1995.
  • 4Mutsukado M,Tanikawa K,Shikada K,et al.3(2H)-Pyridazinone,process for its preparation and anti-allergic agent containing it[P].US:4892947,1990.
  • 5Jeffery JE,Kerrigan F,Miller TK,et al.Synthesis of sibutramine,a novel cyclobutylalkylamine useful in the treatment of obesity,and its major human metabolites[J].J Chem Soc Perkin Trans 1,1996,21:2583-9.
  • 6Wijtmans M,Pratt DA,Brinkhorst J,et al.Synthesis and reactivity of some 6-substituted-2,4-dimethyl-3-pyridinols,a novel class of chain-breakingantioxidants[J].J OrgChem,2004,69 (26):9215 -23.
  • 7Wawzonek S,McKillip W,Peterson CJ.N-Methylethylamine[J].Org Synth,1964,44:75-8.
  • 8Cotrel C,Crisan C,Jeanmart C,et al.Heterocyclic compounds for pharma-ceutical use[P].US 4131674,1978.
  • 9Stepankova H,Hajicek J,Simek S.Process for preparing (-)-(S)-3-[1-(dimethyl-amino)ethyl]phenyl N-ethyl-N-methylcarbamate (rivastigmine)[P].WO 2004037771,2004.
  • 10Amstutz R,Enz A,Matzi M,et al.Cyclische phenylcarba-mate des Miotin-Typs und ihre wirkung anf die acetylcholinesterase[J].Helv Chim Acta,1990,73(3):739-53.

共引文献179

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部